ReviewMoving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice
Under a Creative Commons license
open access
Abbreviations
CDMS
clinically definite multiple sclerosis
CI
confidence interval
CNS
central nervous system
DMD
disease-modifying drug
FCDE
first clinical demyelinating event
GA
glatiramer acetate
Gd
gadolinium
HR
hazard ratio
IFNβ
interferon beta
MRI
magnetic resonance imaging
MS
multiple sclerosis
q.w.
once weekly
s.c.
subcutaneous(ly)
t.i.w.
three times weekly
Keywords
Interferon beta
Glatiramer acetate
First clinical demyelinating event
Clinically isolated syndrome
Disease-modifying drug
Multiple sclerosis
Cited by (0)
- 1
Affiliation at the time of manuscript preparation.
Copyright © 2013 The Authors. Published by Elsevier B.V.